BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8239983)

  • 1. Cardiac preconditioning. Induction of endogenous tolerance to ischemia-reperfusion injury.
    Meldrum DR; Mitchell MB; Banerjee A; Harken AH
    Arch Surg; 1993 Nov; 128(11):1208-11. PubMed ID: 8239983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ischemic preconditioning against infarction: its mechanism and clinical implications.
    Miura T; Miki T; Tsuchihashi K; Iimura O
    EXS; 1996; 76():365-82. PubMed ID: 8805806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of myocardial protection from ischemic preconditioning following chronic exposure to R(-)-N6-(2-phenylisopropyl)adenosine is related to defect at the adenosine A1 receptor.
    Hashimi MW; Thornton JD; Downey JM; Cohen MV
    Mol Cell Biochem; 1998 Sep; 186(1-2):19-25. PubMed ID: 9774181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine and cardioprotection during reperfusion--an overview.
    Donato M; Gelpi RJ
    Mol Cell Biochem; 2003 Sep; 251(1-2):153-9. PubMed ID: 14575317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 1.
    Kloner RA; Jennings RB
    Circulation; 2001 Dec; 104(24):2981-9. PubMed ID: 11739316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic myocardial preconditioning with monophosphoryl lipid A (MLA) reduces infarct size and stunning in dogs and rabbits.
    Elliott GT
    Ann N Y Acad Sci; 1996 Sep; 793():386-99. PubMed ID: 8906181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardioprotective actions of adenosine and adenosine analogs.
    Cook MA; Karmazyn M
    EXS; 1996; 76():325-44. PubMed ID: 8805804
    [No Abstract]   [Full Text] [Related]  

  • 9. Intermittent aortic crossclamping prevents cumulative adenosine triphosphate depletion, ventricular fibrillation, and dysfunction (stunning): is it preconditioning?
    Abd-Elfattah AS; Ding M; Wechsler AS
    J Thorac Cardiovasc Surg; 1995 Aug; 110(2):328-39. PubMed ID: 7637350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ischaemic preconditioning: present position and future directions.
    Yellon DM; Baxter GF; Garcia-Dorado D; Heusch G; Sumeray MS
    Cardiovasc Res; 1998 Jan; 37(1):21-33. PubMed ID: 9539854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [-Myocardial protection by preconditioning. Experimental and clinical significance-].
    Strasser R; Vogt A; Schaper W
    Z Kardiol; 1996 Feb; 85(2):79-89. PubMed ID: 8650986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed protection of the ischemic heart--from pathophysiology to therapeutic applications.
    Richard V; Kaeffer N; Thuillez C
    Fundam Clin Pharmacol; 1996; 10(5):409-15. PubMed ID: 8902543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 2.
    Kloner RA; Jennings RB
    Circulation; 2001 Dec; 104(25):3158-67. PubMed ID: 11748117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ischaemic preconditioning is protein kinase C dependent but not through stimulation of alpha adrenergic or adenosine receptors in the isolated rat heart.
    Bugge E; Ytrehus K
    Cardiovasc Res; 1995 Mar; 29(3):401-6. PubMed ID: 7781014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the Role of TRPV and CGRP in Adenosine Preconditioning and Remote Hind Limb Preconditioning-Induced Cardioprotection in Rats.
    Singh A; Randhawa PK; Bali A; Singh N; Jaggi AS
    Cardiovasc Drugs Ther; 2017 Apr; 31(2):133-143. PubMed ID: 28194544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ischemic preconditioning: cardioprotection for cardiac surgery.
    Ikonomidis JS; Weisel RD; Mickle DA
    J Card Surg; 1994 May; 9(3 Suppl):526-31. PubMed ID: 8069047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harnessing an endogenous cardioprotective mechanism: cellular sources and sites of action of adenosine.
    Mullane K; Bullough D
    J Mol Cell Cardiol; 1995 Apr; 27(4):1041-54. PubMed ID: 7563101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Stunning, preconditioning and hibernation; aspects of ischemia and reperfusion of the myocardium].
    Ruigrok TJ
    Ned Tijdschr Geneeskd; 1993 Dec; 137(49):2526-32. PubMed ID: 8272138
    [No Abstract]   [Full Text] [Related]  

  • 19. Ischemic preconditioning is associated with a delay in ischemia-induced reduction of beta-adrenergic signal transduction in rabbit hearts.
    Iwase T; Murakami T; Tomita T; Miki S; Nagai K; Sasayama S
    Circulation; 1993 Dec; 88(6):2827-37. PubMed ID: 8252696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ischemic preconditioning and adenosine pretreatment on myocardial function and energetics in a clinically relevant model.
    Phillips AB; Ko W
    Life Sci; 2007 Oct; 81(17-18):1355-61. PubMed ID: 17936310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.